What is the VIVI Cap and how does it work?

The VIVI Cap is a patented device that uses vacuum insulation and phase-change materials to keep injectables like insulin and EpiPens at a safe temperature without electricity.

Which health services in Israel now offer TempraMed products?

Maccabi Healthcare Services, serving over 2.8 million members, now offers TempraMed's VIVI Cap and VIVI EPI products.

Who benefits from TempraMed's VIVI Cap technology?

Individuals using injectables such as insulin or EpiPens, particularly those managing diabetes or anaphylaxis, benefit from consistent medication protection.

Home / Health / TempraMed VIVI Cap Reaches Israel

TempraMed VIVI Cap Reaches Israel

9 Dec

•

Summary

TempraMed's VIVI Cap and VIVI EPI are now available in Israel.
The devices maintain injectables at a safe temperature without power.
Maccabi Healthcare Services serves over 2.8 million members.

TempraMed Technologies Ltd. has achieved a significant commercial milestone with its VIVI Cap and VIVI EPI products now available in Israel. This expansion is facilitated through a partnership with Maccabi Healthcare Services, Israel's second-largest health maintenance organization, which serves more than 2.8 million individuals. This move is a key part of TempraMed's strategy to broaden its global reach and scale its innovative medication temperature-control platform.

The VIVI Cap and VIVI EPI are designed to safeguard temperature-sensitive injectables, such as insulin and EpiPens, from damaging temperature fluctuations. Utilizing a patented system of vacuum insulation and phase-change materials, these devices maintain a safe temperature range without reliance on batteries, refrigeration, or external power sources. The lightweight and reusable nature of these products empowers users with chronic conditions to manage their medications effectively during daily activities and travel.